Ezetimibe and Joint effusion - a phase IV clinical study of FDA data

Summary:

Joint effusion is reported as a side effect among people who take Ezetimibe (ezetimibe), especially for people who are male, 60+ old, also take Prednisone, and have Rheumatoid arthritis.

The phase IV clinical study analyzes which people have Joint effusion when taking Ezetimibe. It is created by eHealthMe based on reports of 30,221 people who have side effects when taking Ezetimibe from the FDA, and is updated regularly.

What is Ezetimibe?

Ezetimibe has active ingredients of ezetimibe. It is often used in high blood cholesterol. eHealthMe is studying from 30,849 Ezetimibe users. Check the latest studies of Ezetimibe.

What is Joint effusion?

Joint effusion (presence of extra fluid in joint covering) is found to be associated with 872 drugs and 750 conditions by eHealthMe. Check the latest studies of Joint effusion.

On Jul, 18, 2026

30,221 people reported to have side effects when taking Ezetimibe.
Among them, 33 people (0.11%) have Joint effusion.

Among these 33 people:

What is the gender of people who have Joint effusion when taking Ezetimibe? *

female: 39.29 %
male: 60.71 %

What is the age of people who have Joint effusion when taking Ezetimibe? *

What are other drugs people take besides Ezetimibe? *

Prednisone: 16 people, 48.48%
Acetaminophen: 11 people, 33.33%
Humira: 11 people, 33.33%
Furosemide: 10 people, 30.30%
Methylprednisolone: 9 people, 27.27%
Digoxin: 9 people, 27.27%
Diphenhydramine Hydrochloride: 9 people, 27.27%
Nifedipine: 9 people, 27.27%
Sulfasalazine: 9 people, 27.27%
Fluconazole: 8 people, 24.24%

What are other side effects people have besides Joint effusion? *

Back Pain: 17 people, 51.52%
Pain: 16 people, 48.48%
Arrhythmias (irregular heartbeat): 16 people, 48.48%
Anaemia (lack of blood): 16 people, 48.48%
Rotator Cuff Syndrome (a spectrum of conditions affecting the rotator cuff tendons of the shoulder): 16 people, 48.48%
Osteoporosis (bones weak and more likely to break): 16 people, 48.48%
Hepatic Steatosis (fatty liver disease): 15 people, 45.45%
Fever: 15 people, 45.45%
Rashes (redness): 15 people, 45.45%
Drug Ineffective: 14 people, 42.42%

What are the existing conditions these people have? *

Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 12 people, 36.36%
Antinuclear Antibody Positive: 8 people, 24.24%
Aortic Valve Incompetence: 8 people, 24.24%
Breast Cancer Metastatic: 8 people, 24.24%
Dermatomyositis (inflammation of the skin and underlying muscle tissue, typically occurring as an autoimmune condition or associated with internal cancer): 8 people, 24.24%
Haemorrhage (bleeding): 8 people, 24.24%
Arthritis (form of joint disorder that involves inflammation of one or more joints): 7 people, 21.21%
High Blood Pressure: 4 people, 12.12%
Cardiac Disorder: 2 people, 6.06%
Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 2 people, 6.06%

* Approximation only. Some reports may have incomplete information.

Do you take Ezetimibe and have Joint effusion?

- Check whether Joint effusion is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Ezetimibe:

Ezetimibe (30,849 reports)

Joint effusion treatments and more:

Joint effusion (9,947 reports)

Browse all side effects of Ezetimibe:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Joint effusion:

Joint effusion (872 drugs)

Browse all the conditions that are associated with Joint effusion:

Joint effusion (750 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on ezetimibe (the active ingredients of Ezetimibe) and Ezetimibe (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.